Tag: NMPA-approved cell therapy

Home / NMPA-approved cell therapy

Categories

NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma

Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has r...
nmpa-approved-cell-therapy

Scan the code